Kidney donation from a patient with cardiac myxoma: a case report
| Autor: | Ł. Hałoń, M. Wolański, M. Boratyńska, D.J. Patrzałek, A. Hałoń |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Urinary system Kidney Organ transplantation Heart Neoplasms Fatal Outcome medicine Humans Kidney transplantation Aged 80 and over Transplantation medicine.diagnostic_test business.industry Myxoma Middle Aged medicine.disease Kidney Transplantation Tissue Donors Surgery medicine.anatomical_structure Echocardiography Female Hemodialysis Renal biopsy business |
| Zdroj: | Transplantation proceedings. 40(4) |
| ISSN: | 0041-1345 |
| Popis: | Introduction. Renal transplantation has still become the preferred method to treat end-stage renal failure. The majority of organs are obtained from individuals with irreversible central nervous system injury. This group is nowadays unsatisfactory and small relative to the needs. A significant percentage of donors may be found among patients primarily suffering from benign neoplasms whose nature does not show malignant potential and do not metastasize. To date, there have been no reports about successful organ transplantation from an organ donor with cardiac myxoma. Aim. The aim of this report was to present a successful transplantation of cadaveric kidney grafts from a 61-year-old female donor with a left atrial cardiac myxoma, which initially appeared as an embolic cerebral infarct. The kidney graft recipients were a 51-year-old woman and a 57-year-old man with long-lasting histories of chronic renal failure under treatment by hemodialysis. The transplant function of both kidneys has been satisfactory with a 5-year follow-up. For the present, apart from single event of acute rejection in a male recipient, the patients have maintained stable renal function. Routine accessory examinations did not reveal any changes within the kidney or other organs. To date, a renal biopsy has not been taken. Both recipients are undergoing special follow-up. Conclusion. Patients with myxoma should be accepted as donors, since the risk of dying on the waiting list is greater than the tumor transfer risk. Exclusion of these potential donors decreases the donor pool and unnecessarily wastes valuable organs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect